HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rudolf Hartung Selected Research

alfuzosin (UroXatral)

4/2008Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
3/2006Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
8/2005Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
3/2005Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rudolf Hartung Research Topics

Disease

7Neoplasms (Cancer)
12/2009 - 03/2003
5Prostatic Neoplasms (Prostate Cancer)
12/2009 - 09/2004
4Lower Urinary Tract Symptoms
04/2008 - 03/2005
2Carcinoma (Carcinomatosis)
12/2009 - 03/2003
2Dizziness (Lightheadedness)
04/2008 - 03/2006
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2008 - 08/2005
1Carcinogenesis
10/2007
1Prostatic Intraepithelial Neoplasia
10/2007
1Prostatitis
10/2007
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2006
1Hyperplasia
03/2006
1Urinary Retention
08/2005
1Neoplasm Metastasis (Metastasis)
06/2005
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
03/2005
1Renal Cell Carcinoma (Grawitz Tumor)
01/2004
1Kidney Neoplasms (Kidney Cancer)
01/2004
1Melanoma (Melanoma, Malignant)
03/2003
1Lymphoma (Lymphomas)
03/2003

Drug/Important Bio-Agent (IBA)

4alfuzosin (UroXatral)FDA Link
04/2008 - 03/2005
2Dihydrotachysterol (AT 10)IBA
04/2008 - 08/2005
2Prostate-Specific Antigen (Semenogelase)IBA
01/2006 - 08/2005
1Interleukin-2 (IL2)IBA
12/2009
1HLA-A*02:01 antigenIBA
12/2009
1Interferon-gamma (Interferon, gamma)IBA
12/2009
1Cancer VaccinesIBA
12/2009
1Biological ProductsIBA
10/2007
1EnzymesIBA
10/2007
1Glutathione Transferase (Glutathione S-Transferase)IBA
10/2007
1Proteins (Proteins, Gene)FDA Link
07/2006
1multidrug resistance-associated protein 1IBA
07/2006
1Imatinib Mesylate (Gleevec)FDA Link
06/2005
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
06/2005
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2005
1Hormones (Hormone)IBA
06/2005
1Antineoplastic Agents (Antineoplastics)IBA
06/2005
1Cell Adhesion MoleculesIBA
01/2004
1Cadherins (E-Cadherin)IBA
01/2004
1K cadherinIBA
01/2004
1Keratin-18 (Keratin 18)IBA
03/2003
1Keratins (Keratin)IBA
03/2003
1EpitopesIBA
03/2003
1AntibodiesIBA
03/2003

Therapy/Procedure

3Prostatectomy (Retropubic Prostatectomy)
01/2006 - 09/2004
1Castration
12/2009
1Immunotherapy
12/2009
1Intradermal Injections
12/2009
1Therapeutics
07/2006
1Transurethral Resection of Bladder
06/2006
1Lymph Node Excision (Lymph Node Dissection)
06/2006
1Cystectomy
06/2006
1Blood Transfusion (Blood Transfusions)
01/2006
1Nephrectomy
01/2004
1Orchiectomy (Orchidectomy)
03/2003